Pharmacotherapy: vandetanib-a new therapeutic option in advanced medullary thyroid cancer
- PMID: 22083086
- DOI: 10.1038/nrendo.2011.198
Pharmacotherapy: vandetanib-a new therapeutic option in advanced medullary thyroid cancer
Comment on
-
Vandetanib in patients with locally advanced or metastatic medullary thyroid cancer: a randomized, double-blind phase III trial.J Clin Oncol. 2012 Jan 10;30(2):134-41. doi: 10.1200/JCO.2011.35.5040. Epub 2011 Oct 24. J Clin Oncol. 2012. PMID: 22025146 Free PMC article. Clinical Trial.
References
-
- J Clin Oncol. 2012 Jan 10;30(2):134-41 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
